ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

169
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
bullish•Parkway Pantai Ltd
•03 Aug 2020 00:19

Parkway Pantai: Good Brand with Limited Upside

We initiate our coverage of Parkway Pantai Ltd (0794727D SP) (Parkway Pantai), a wholly-owned subsidiary of IHH Healthcare (IHH MK) of which major...

Logo
536 Views
Share
•30 Jul 2020 08:54

Morning Views Asia: Glenmark Pharmaceuticals, Redco Properties

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
341 Views
Share
•28 Jul 2020 17:09

Asia HY Trade Recommendations - July 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of July includes a summary of our recommendations, as well as our high-conviction ideas....

Logo
367 Views
Share
•13 Jul 2020 08:53

Morning Views Asia: Alam Sutera Realty, Glenmark Pharmaceuticals

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
281 Views
Share
•03 Jul 2020 15:58

Asia HY Monthly - Framework For Discerning Fraud In Asian Companies - Lucror Analytics

Following the recent string of high-profile fraud scandals, from Luckin Coffee in China to Wirecard in Germany, our In-Focus section this month...

Logo
454 Views
Share
x